TheraRadar
Data updated: Mar 29, 2026

AIRDUO DIGIHALER

FLUTICASONE PROPIONATE
Approved 2017-01-27
2
Indications
--
Phase 3 Trials
9
Years on Market

Details

Status
Discontinued
First Approved
2017-01-27
Routes
INHALATION
Dosage Forms
POWDER

Companies

AIRDUO DIGIHALER Approval History

Loading approval history...

What AIRDUO DIGIHALER Treats

2 FDA approvals

Originally approved for its first indication in 2017 . Covers 2 distinct patient populations.

  • Other (2)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

AIRDUO DIGIHALER FDA Label Details

Pro

AIRDUO DIGIHALER Patents & Exclusivity

Latest Patent: Jan 2041

Patents (174 active)

US11173259*PED Expires Jan 6, 2041
US11173259 Expires Jul 6, 2040
US11344685*PED Expires Mar 26, 2040
US11969544*PED Expires Feb 20, 2040
US11344685 Expires Sep 26, 2039
US11969544 Expires Aug 20, 2039
US10918816*PED Expires Jun 14, 2036
US10918816 Expires Dec 14, 2035
US9415008*PED Expires Apr 6, 2035
US9066957*PED Expires Apr 6, 2035
+ 164 more patents
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.